SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Atreca, Inc. (BCEL) .
Criteria proven by this page:
- VALUE (100/100, Pass) — analyst target implies upside (+4344.4%).
- Analyst consensus target $4.00 (+4344.4% upside) — significant upside potential according to Wall Street analysts.
Overall SharesGrow Score: 38/100 with 3/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
75/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — BCEL
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio4.51
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-2.35
Book Value / Share$0.00
Revenue / Share$0.02
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
Analyst Target$4.00 (+4344.4%)
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2017 |
$-12.44 |
$0.00 |
$-27.53M |
- |
| 2018 |
$-11.75 |
$0.00 |
$-37.94M |
- |
| 2019 |
$-4.26 |
$2.13M |
$-67.48M |
-3162.3% |
| 2020 |
$-2.70 |
$1.35M |
$-86.34M |
-6381% |
| 2021 |
$-2.95 |
$851K |
$-109.33M |
-12846.8% |
| 2022 |
$-2.35 |
$770K |
$-90.53M |
-11756.5% |
